TVTX logo

Travere Therapeutics, Inc. (TVTX) Cash from investing

annual CFI:

$99.33M+$43.55M(+78.08%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual cash flow from investing activities is $99.33 million, with the most recent change of +$43.55 million (+78.08%) on December 31, 2024.
  • During the last 3 years, TVTX annual CFI has risen by +$236.95 million (+172.17%).
  • TVTX annual CFI is now at all-time high.

Performance

TVTX Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

quarterly CFI:

$4.85M-$36.44M(-88.25%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly cash flow from investing activities is $4.85 million, with the most recent change of -$36.44 million (-88.25%) on June 30, 2025.
  • Over the past year, TVTX quarterly CFI has dropped by -$23.76 million (-83.05%).
  • TVTX quarterly CFI is now -96.36% below its all-time high of $133.32 million, reached on September 30, 2023.

Performance

TVTX quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

TTM CFI:

$11.96M-$23.76M(-66.52%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX TTM cash flow from investing activities is $11.96 million, with the most recent change of -$23.76 million (-66.52%) on June 30, 2025.
  • Over the past year, TVTX TTM CFI has dropped by -$237.92 million (-95.21%).
  • TVTX TTM CFI is now -95.21% below its all-time high of $249.88 million, reached on June 30, 2024.

Performance

TVTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TVTX Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+78.1%-83.0%-95.2%
3 y3 years+172.2%+112.4%-64.8%
5 y5 years+400.1%-92.8%-89.5%

TVTX Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+172.2%-96.4%+106.0%-95.2%+111.6%
5 y5-yearat high+172.2%-96.4%+103.9%-95.2%+103.5%
alltimeall timeat high+148.9%-96.4%+103.0%-95.2%+103.5%

TVTX Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.85M(-88.3%)
$11.96M(-66.5%)
Mar 2025
-
$41.29M(-151.4%)
$35.72M(-64.0%)
Dec 2024
$99.33M(+78.1%)
-$80.31M(-274.1%)
$99.33M(-38.9%)
Sep 2024
-
$46.13M(+61.2%)
$162.68M(-34.9%)
Jun 2024
-
$28.61M(-72.7%)
$249.88M(+26.4%)
Mar 2024
-
$104.90M(-718.9%)
$197.71M(+254.5%)
Dec 2023
$55.78M(-271.3%)
-$16.95M(-112.7%)
$55.78M(+54.8%)
Sep 2023
-
$133.32M(-666.0%)
$36.02M(-141.3%)
Jun 2023
-
-$23.55M(-36.4%)
-$87.21M(-15.1%)
Mar 2023
-
-$37.04M(+0.9%)
-$102.76M(+215.7%)
Dec 2022
-$32.55M(-76.3%)
-$36.70M(-464.1%)
-$32.55M(-382.6%)
Sep 2022
-
$10.08M(-125.8%)
$11.52M(-66.1%)
Jun 2022
-
-$39.10M(-217.9%)
$33.96M(+2621.1%)
Mar 2022
-
$33.16M(+350.0%)
$1.25M(-100.9%)
Dec 2021
-$137.62M(+124.4%)
$7.37M(-77.3%)
-$137.62M(-49.1%)
Sep 2021
-
$32.52M(-145.3%)
-$270.50M(-21.9%)
Jun 2021
-
-$71.81M(-32.1%)
-$346.19M(+67.6%)
Mar 2021
-
-$105.71M(-15.8%)
-$206.58M(+236.9%)
Dec 2020
-$61.33M(-408.7%)
-$125.51M(+190.7%)
-$61.33M(-193.3%)
Sep 2020
-
-$43.17M(-163.7%)
$65.76M(-42.0%)
Jun 2020
-
$67.80M(+71.4%)
$113.40M(+60.1%)
Mar 2020
-
$39.55M(+2403.2%)
$70.83M(+256.6%)
Dec 2019
$19.86M(-109.8%)
$1.58M(-64.6%)
$19.86M(-165.1%)
Sep 2019
-
$4.46M(-82.3%)
-$30.52M(-84.5%)
Jun 2019
-
$25.23M(-321.1%)
-$196.53M(+1.4%)
Mar 2019
-
-$11.41M(-76.6%)
-$193.85M(-4.6%)
Dec 2018
-$203.29M(-545.8%)
-$48.80M(-69.8%)
-$203.29M(+31.5%)
Sep 2018
-
-$161.54M(-678.9%)
-$154.59M(-3344.3%)
Jun 2018
-
$27.91M(-233.8%)
$4.76M(-76.9%)
Mar 2018
-
-$20.85M(>+9900.0%)
$20.63M(-54.8%)
Dec 2017
$45.60M
-$103.00K(-95.3%)
$45.60M(-40.2%)
Sep 2017
-
-$2.19M(-105.0%)
$76.29M(+5.5%)
Jun 2017
-
$43.77M(+961.0%)
$72.31M(+198.2%)
DateAnnualQuarterlyTTM
Mar 2017
-
$4.13M(-86.5%)
$24.25M(+133.9%)
Dec 2016
$10.37M(-112.9%)
$30.59M(-595.9%)
$10.37M(-108.6%)
Sep 2016
-
-$6.17M(+43.7%)
-$120.68M(+90.4%)
Jun 2016
-
-$4.29M(-56.0%)
-$63.39M(+4.8%)
Mar 2016
-
-$9.76M(-90.3%)
-$60.50M(-24.9%)
Dec 2015
-$80.60M(+116.3%)
-$100.46M(-296.5%)
-$80.60M(-469.2%)
Sep 2015
-
$51.12M(-3751.8%)
$21.83M(-169.6%)
Jun 2015
-
-$1.40M(-95.3%)
-$31.35M(-12.9%)
Mar 2015
-
-$29.86M(-1616.0%)
-$36.01M(-3.4%)
Dec 2014
-$37.26M(+589.2%)
$1.97M(-195.5%)
-$37.26M(-1.9%)
Sep 2014
-
-$2.06M(-66.0%)
-$37.97M(-8.0%)
Jun 2014
-
-$6.06M(-80.5%)
-$41.26M(+17.2%)
Mar 2014
-
-$31.11M(-2561.5%)
-$35.21M(+551.3%)
Dec 2013
-$5.41M(+218.1%)
$1.26M(-123.6%)
-$5.41M(-18.9%)
Sep 2013
-
-$5.36M(>+9900.0%)
-$6.67M(+407.1%)
Jun 2013
-
-$8600.00(-99.3%)
-$1.32M(+0.7%)
Mar 2013
-
-$1.31M(<-9900.0%)
-$1.31M(<-9900.0%)
Dec 2012
-$1.70M(<-9900.0%)
-
-
Nov 2011
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2011
-
$0.00(0.0%)
$0.00(0.0%)
May 2011
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2011
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Nov 2010
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2010
-
$0.00(0.0%)
$0.00(0.0%)
May 2010
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2010
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Nov 2009
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2009
-
$0.00(0.0%)
$0.00(0.0%)
May 2009
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2009
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Nov 2008
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2008
-
$0.00(0.0%)
$0.00(0.0%)
May 2008
-
$0.00
$0.00
Feb 2008
$0.00
-
-

FAQ

  • What is Travere Therapeutics, Inc. annual cash flow from investing activities?
  • What is the all time high annual CFI for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual CFI year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly CFI year-on-year change?
  • What is Travere Therapeutics, Inc. TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. TTM CFI year-on-year change?

What is Travere Therapeutics, Inc. annual cash flow from investing activities?

The current annual CFI of TVTX is $99.33M

What is the all time high annual CFI for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual cash flow from investing activities is $99.33M

What is Travere Therapeutics, Inc. annual CFI year-on-year change?

Over the past year, TVTX annual cash flow from investing activities has changed by +$43.55M (+78.08%)

What is Travere Therapeutics, Inc. quarterly cash flow from investing activities?

The current quarterly CFI of TVTX is $4.85M

What is the all time high quarterly CFI for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $133.32M

What is Travere Therapeutics, Inc. quarterly CFI year-on-year change?

Over the past year, TVTX quarterly cash flow from investing activities has changed by -$23.76M (-83.05%)

What is Travere Therapeutics, Inc. TTM cash flow from investing activities?

The current TTM CFI of TVTX is $11.96M

What is the all time high TTM CFI for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high TTM cash flow from investing activities is $249.88M

What is Travere Therapeutics, Inc. TTM CFI year-on-year change?

Over the past year, TVTX TTM cash flow from investing activities has changed by -$237.92M (-95.21%)
On this page